TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD Investments/Divestments 8-K Filing 2023 - Collaboration with Sanofi Teva Pharmaceutical Industries Ltd. announced a collaboration with Sanofi to co-develop and co-commercialize a therapy for ulcerative colitis and Crohn's disease.Get access to all SEC 8-K filings of the TEVA PHARMACEUTICAL INDUSTRIES LTD